Results 41 to 50 of about 2,119 (184)

CLINICAL AND GENETIC, MICROBIOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF MOSCOW AND MOSCOW REGION PATIENTS WITH CYSTIC FIBROSIS

open access: yesВопросы современной педиатрии, 2013
The aim of this study was to assess different clinical and genetic, microbiological and functional features of patients with cystic fibrosis living in Moscow and Moscow region on the 31st December, 2010. The mean age of the patients was 12,1±9,6 years (0,
S. A. Krasovskii   +13 more
doaj   +1 more source

THE REGISTER AS A MEANS OF IMPROVING THE QUALITY OF MUCOVISCIDOSIS PATIENTS’ TREATMENT

open access: yesПедиатрическая фармакология, 2012
The creation of a register of mucoviscidosis (MV) patients is necessary for determining the epidemic situation in the region, evaluating the efficacy of therapeutic strategies and the quality of healthcare provided.
I. K. Asherova, N. I. Kapranov
doaj   +1 more source

A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA

open access: yesПедиатрическая фармакология, 2012
Chronic inflammation of airways always takes place in case of cystic fibrosis. Being a powerful mucolytic, dornase alfa also has antiinflammatory and antibacterial qualities.
O. I. Simonova   +2 more
doaj   +1 more source

Poorer European Countries are Less Concerned about Biotechnology than Richer Countries [PDF]

open access: yes, 2001
The author examines the relationship between GNP, media coverage, and public perceptions of the utility, risk, and acceptability of medical and food-related applications of ...
Siegrist, Michael
core   +1 more source

Methods for Discerning the Impact of Mucus on Host Defenses Against Viral Infection

open access: yesCurrent Protocols, Volume 5, Issue 9, September 2025.
Abstract Mucus is an important component of airway host defenses that acts by enabling the trapping and clearance of infectious materials such as bacteria and viruses. It can be difficult, however, to design experiments that independently determine the extent to which mucus contributes to innate barrier functions in the lung.
Maria Corkran   +3 more
wiley   +1 more source

PSYCHOLOGICAL-PEDAGOGICAL ASPECTS OF TREATING CHILDREN WITH MUCOVISCIDOSIS

open access: yesПедиатрическая фармакология, 2014
The article is dedicated to optimization of psychological help rendering to children with mucoviscidosis. The authors emphasize the need in multidisciplinary approach to rehabilitation of such children and present results of a study of psychological ...
T. V. Sviridova   +3 more
doaj   +2 more sources

Promoting Patient Safety Through Patient Engagement at the Organisational Level: A Delphi‐Based Needs Assessment Among Patient and Family Advisory Councils

open access: yesHealth Expectations, Volume 28, Issue 3, June 2025.
ABSTRACT Background Patient and family advisory councils (PFACs) are increasingly recognised as a promising approach for improving patient safety (PS) through patient engagement (PE) at the organisational level. However, PFAC stakeholders often lack the necessary knowledge and competence to engage effectively in PS‐related issues with healthcare ...
Larissa Brust   +2 more
wiley   +1 more source

Uncommon histopathological oral findings in an autopsied infant with cystic fibrosis.

open access: yesBrazilian Journal of Oral Sciences, 2015
Cystic Fibrosis or Mucoviscidosis is a hereditary genetic disease that attacks mainly children and young adults. It is characterized by a general dysfunction of the exocrine glands.
Eduardo Rodrigues Fregnani   +5 more
doaj   +1 more source

PEG closure in the second attempt

open access: yesEndoscopy International Open, 2016
Background and study aims: This case report demonstrates successful endoscopic treatment of a persistent gastrocutaneous fistula after removal of a percutaneous endoscopic gastrostomy (PEG) in a 21-year-old patient with mucoviscidosis after lung ...
Leif Schiffmann   +2 more
doaj   +1 more source

The Challenges and Promises of New Therapies for Cystic Fibrosis [PDF]

open access: yes, 2013
Therapeutic intervention in cystic fibrosis (CF) remains a challenge, partly because of the number of organs and tissues affected by the lack of a functional cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Pier, Gerald B.
core   +1 more source

Home - About - Disclaimer - Privacy